Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.
2.

Cholecystokinin and panic disorder: past and future clinical research strategies.

Bradwejn J, Koszycki D.

Scand J Clin Lab Invest Suppl. 2001;234:19-27. Review.

PMID:
11713976
3.

[Neurobiology and pharmacotherapy of social phobia].

Aouizerate B, Martin-Guehl C, Tignol J.

Encephale. 2004 Jul-Aug;30(4):301-13. Review. French.

PMID:
15538306
4.

HPA axis activity in patients with panic disorder: review and synthesis of four studies.

Abelson JL, Khan S, Liberzon I, Young EA.

Depress Anxiety. 2007;24(1):66-76. Review.

5.

On the significance of cholecystokinin receptors in panic disorder.

van Megen HJ, den Boer JA, Westenberg HG.

Prog Neuropsychopharmacol Biol Psychiatry. 1994 Dec;18(8):1235-46. Review.

PMID:
7863014
6.

Cholecystokinin and panic disorder--three unsettled questions.

Rehfeld JF.

Regul Pept. 2000 Sep 25;93(1-3):79-83. Review.

PMID:
11033055
7.

CCK in anxiety and cognitive processes.

Daugé V, Léna I.

Neurosci Biobehav Rev. 1998 Oct;22(6):815-25. Review.

PMID:
9809313
8.

Neurobiological investigations into the role of cholecystokinin in panic disorder.

Bradwejn J.

J Psychiatry Neurosci. 1993 Jul;18(4):178-88. Review.

9.

The cholecystokinin hypothesis of anxiety and panic disorder.

Bradwejn J, Koszycki D.

Ann N Y Acad Sci. 1994 Mar 23;713:273-82. Review. No abstract available.

PMID:
8185169
10.

[From inducers of panic attack to neurobiology of panic disorder].

Bourin M.

Encephale. 1996 Dec;22 Spec No 5:35-41. Review. French.

PMID:
9138945
11.

[Stress, anxiety, panic. Panic attack and panic disorder. A new psychiatric concept].

Bourgeois M.

Encephale. 1993 Mar;19 Spec No 1:187-91. Review. French.

PMID:
8281900
12.

[Cholecystokinin antagonists: anxiolytic drugs of the future].

Bourin M, Bradwejn J.

Pathol Biol (Paris). 1992 Mar;40(3):215-7. Review. French. No abstract available.

PMID:
1608663
13.

The 35% carbon dioxide test in stress and panic research: overview of effects and integration of findings.

Vickers K, Jafarpour S, Mofidi A, Rafat B, Woznica A.

Clin Psychol Rev. 2012 Apr;32(3):153-64. doi: 10.1016/j.cpr.2011.12.004. Epub 2012 Jan 5. Review.

PMID:
22322014
14.

Neuronal network of panic disorder: the role of the neuropeptide cholecystokinin.

Zwanzger P, Domschke K, Bradwejn J.

Depress Anxiety. 2012 Sep;29(9):762-74. doi: 10.1002/da.21919. Epub 2012 May 2. Review.

PMID:
22553078
15.

How good are patients with panic disorder at perceiving their heartbeats?

Ehlers A, Breuer P.

Biol Psychol. 1996 Jan 5;42(1-2):165-82. Review.

PMID:
8770377
16.

An animal model of panic vulnerability with chronic disinhibition of the dorsomedial/perifornical hypothalamus.

Johnson PL, Shekhar A.

Physiol Behav. 2012 Dec 5;107(5):686-98. doi: 10.1016/j.physbeh.2012.03.016. Epub 2012 Mar 26. Review.

17.

Arousal and the attentional network in panic disorder.

Geiger MJ, Neufang S, Stein DJ, Domschke K.

Hum Psychopharmacol. 2014 Nov;29(6):599-603. doi: 10.1002/hup.2436. Epub 2014 Oct 14. Review.

PMID:
25311787
18.

CCK in animal and human research on anxiety.

Harro J, Vasar E, Bradwejn J.

Trends Pharmacol Sci. 1993 Jun;14(6):244-9. Review.

PMID:
8372405
19.

Cholecystokinin and anxiety.

Ravard S, Dourish CT.

Trends Pharmacol Sci. 1990 Jul;11(7):271-3. Review. No abstract available.

PMID:
2202139

Supplemental Content

Support Center